[go: up one dir, main page]

GB9910773D0 - Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract - Google Patents

Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract

Info

Publication number
GB9910773D0
GB9910773D0 GBGB9910773.2A GB9910773A GB9910773D0 GB 9910773 D0 GB9910773 D0 GB 9910773D0 GB 9910773 A GB9910773 A GB 9910773A GB 9910773 D0 GB9910773 D0 GB 9910773D0
Authority
GB
United Kingdom
Prior art keywords
minimise
drugs
food
absorption
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9910773.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
West Pharmaceutical Services Drug Delivery and Clinical Research Center Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharmaceutical Services Drug Delivery and Clinical Research Center Ltd filed Critical West Pharmaceutical Services Drug Delivery and Clinical Research Center Ltd
Priority to GBGB9910773.2A priority Critical patent/GB9910773D0/en
Publication of GB9910773D0 publication Critical patent/GB9910773D0/en
Priority to GB0011232A priority patent/GB2352172A/en
Ceased legal-status Critical Current

Links

GBGB9910773.2A 1999-05-11 1999-05-11 Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract Ceased GB9910773D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB9910773.2A GB9910773D0 (en) 1999-05-11 1999-05-11 Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0011232A GB2352172A (en) 1999-05-11 2000-05-11 Orally administered dose unit comprising a drug with an outer coating of an enteric polymer, which allows co-administered food to separate from the dose unit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9910773.2A GB9910773D0 (en) 1999-05-11 1999-05-11 Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract

Publications (1)

Publication Number Publication Date
GB9910773D0 true GB9910773D0 (en) 1999-07-07

Family

ID=10853138

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9910773.2A Ceased GB9910773D0 (en) 1999-05-11 1999-05-11 Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0011232A Withdrawn GB2352172A (en) 1999-05-11 2000-05-11 Orally administered dose unit comprising a drug with an outer coating of an enteric polymer, which allows co-administered food to separate from the dose unit

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0011232A Withdrawn GB2352172A (en) 1999-05-11 2000-05-11 Orally administered dose unit comprising a drug with an outer coating of an enteric polymer, which allows co-administered food to separate from the dose unit

Country Status (1)

Country Link
GB (2) GB9910773D0 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818550B1 (en) * 2000-12-26 2003-02-07 Servier Lab SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITION FOR THE CONTROLLED RELEASE OF PERINDOPRIL
FR2841140B1 (en) * 2002-06-24 2004-10-01 Servier Lab MICROCAPSULES FOR DELAYED AND CONTROLLED RELEASE OF PERINDOPRIL
KR20040076203A (en) * 2003-02-24 2004-08-31 주식회사 엘지생명과학 Orally administrable pharmaceutical compositions and methods for preventing food-drug interaction
ITMI20041295A1 (en) * 2004-06-25 2004-09-25 Cosmo Spa ORAL ANTI-MICROBIAL PHARMACEUTICAL COMPOSITIONS
CN107875136B (en) * 2017-12-27 2021-03-05 广州白云山医药集团股份有限公司白云山制药总厂 Amoxicillin medicinal preparation and preparation method thereof
US11458104B1 (en) * 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59193831A (en) * 1983-04-18 1984-11-02 Sankyo Co Ltd Preparation of enteric drug
JPH064531B2 (en) * 1990-06-04 1994-01-19 アイセロ化学株式会社 Colon disintegrating hard capsule
JPH11510514A (en) * 1996-04-10 1999-09-14 メルク エンド カンパニー インコーポレーテッド Orally coated active drug
GB9801363D0 (en) * 1998-01-22 1998-03-18 Danbiosyst Uk Novel dosage form

Also Published As

Publication number Publication date
GB2352172A (en) 2001-01-24
GB0011232D0 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
PL400027A1 (en) Multielement pharmaceutical dosage form and process for the preparation thereof
EP1216980A4 (en) Carboxylic acid derivatives and drugs containing the same
IL149224A0 (en) Hydrogen-driven drug dosage form
HUP0203204A3 (en) Oral dosage forms
HUP0200329A3 (en) Pharmaceutical formulations for treatment of mucosal associated conditions with an immune response modifier
ZA9811239B (en) Oral pharmaceutical extended release dosage form
GB0117618D0 (en) Pharmaceutical dosage form
HUP0700039A2 (en) Use of cannabinoid drugs for the preparation of medicines for decreasing cell proliferation
HU0000139D0 (en) Medicaments retarded releasing and containing the combination of opioid and alpha-agonist
ZA200506240B (en) Coated particles and pharmaceutical dosage forms
CZ20011186A3 (en) Stabilized pharmaceutical preparation
PL352761A1 (en) Taste masked pharmaceutical liquid formulations
GB0117619D0 (en) Pharmaceutical dosage form
HUP0402230A3 (en) Pharmaceutical dosage form with multiple coatings
IL158671A0 (en) Benzyloxy derivatives and pharmaceutical compositions containing the same
HUP0105204A3 (en) Substituted phenethylamine derivatives and pharmaceutical compositions containing them
IL154850A0 (en) Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same
HUP0203339A3 (en) Ciclesonide contained pharmaceutical composition for application to mucosa
IL162743A0 (en) Tricyclic 2-pyrimidone derivatives and pharmaceutical compositions containing the same
GB9910773D0 (en) Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
IL159084A0 (en) Tetrahydroisoquinoline carboxylic acid derivatives and pharmaceutical compositions containing the same
ZA200003165B (en) Use of melatoninergic ligands in obtaining pharmaceutical compositions intended for prevention of treatment of pathologies of the gastrointestinal system.
AU2003256157A1 (en) Oral dosage forms of water insoluble drugs and methods of making the same
MXPA00012560A (en) Use of interleukin-11 to treat gastrointestinal disorders.
PL375762A1 (en) Nasallly applicable pharmaceutical preparation and the production thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)